APP下载

奥替溴铵联合氟哌噻吨美利曲辛治疗腹泻型肠易激综合征的临床效果

2018-11-10殷春丽奥替溴铵联合氟哌噻吨美利曲辛治疗腹泻型

中国当代医药 2018年19期

殷春丽奥替溴铵联合氟哌噻吨美利曲辛治疗腹泻型

[摘要]目的 觀察奥替溴铵联合氟哌噻吨美利曲辛治疗腹泻型肠易激综合征(IBS-D)的临床效果。方法 选取2014年1月~2016年12月在我院确诊的96例IBS-D患者作为研究对象,随机将其分成观察组(52例)和对照组(44例)。对照组患者单用奥替溴铵治疗,观察组患者采用奥替溴铵联合氟哌噻吨美利曲辛治疗。两组的疗程均为4周。治疗后,比较两组患者的疗效,并通过医院焦虑-抑郁量表(HADS)来分析评价两组患者的精神心理状态。结果 观察组患者的整体疗效优于对照组,差异有统计学意义(P<0.05)。对照组患者的治疗总有效率为75.0%(33/44),治疗组患者的治疗总有效率为88.5%(47/52),两组患者的治疗总有效率比较,差异无统计学意义(P>0.05)。对照组患者治疗前的焦虑评分为(8.14±1.36)分,治疗后为(6.42±1.67)分,观察组患者治疗前的焦虑评分为(8.35±1.44)分,治疗后为(5.38±1.28)分;对照组患者治疗前的抑郁评分为(9.56±1.93)分,治疗后为(6.89±2.02)分,观察组患者治疗前的抑郁评分为(9.68±1.81)分,治疗后为(5.56±1.73)分。治疗后,两组患者的焦虑与抑郁评分均低于治疗前,且观察组患者的患者的焦虑与抑郁评分均低于对照组,差异有统计学意义(P<0.05)。对照组患者的不良反应发生率为4.5%,治疗组患者的不良反应发生率为5.8%,两组患者的不良反应发生率比较,差异无统计学意义(P>0.05)。结论 对IBS-D患者予以奥替溴铵联合氟哌噻吨美利曲辛治疗,可取得更为显著的效果,并有助于更好地改善焦虑抑郁症状。

[关键词]奥替溴铵;氟哌噻吨美利曲辛;腹泻型肠易激综合征;焦虑抑郁

[中图分类号] R574.4 [文献标识码] A [文章编号] 1674-4721(2018)7(a)-0154-04

[Abstract]Objective To observe the clinical effect of Otilonium Bromide combined with Flupenthixol Melitracen in treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).Methods A total of 96 patients diagnosed with IBS-D in our hospital from January 2014 to December 2016 were randomly divided into the observation group (52 cases) and the control group (44 cases).The control group was treated with Otilonium Bromide,while the observation group was treated with Otilonium Bromide combined with Flupenthixol Melitracen.The course of each group was 4 weeks.After treatment,the efficacy of the two groups of patients was compared,and the mental and psychological states of the two groups of patients were analyzed and evaluated by the hospital anxiety-depression scale (HADS).Results The overall curative effect of the observation group was better than that of the control group,and the difference was statistically significant (P<0.05).The total effective rate of the control group was 75.0% (33/44),and the total effective rate of the treatment group was 88.5% (47/52),comparison of total therapeutic efficiency between the two groups showed no statistically significant difference (P>0.05).The anxiety score of the control group was (8.14±1.36) points before treatment and (6.42±1.67) points after treatment,the anxiety score of the observation group was (8.35±1.44) points before treatment and (5.38±1.28) points after treatment.The depression score of the control group was (9.56±1.93) points before treatment and (6.89±2.02) points after treatment.The depression score of the observation group was (9.68±1.81) points before treatment and (5.56±1.73) points after treatment.After treatment,the anxiety and depression scores of both groups were lower than those before treatment and those of the observation group were lower than those of the control group,the differences were statistically significant (P<0.05).The incidence of adverse reactions was 4.5% in the control group and 5.8% in the treatment group,there was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion The treatment of Otilonium Bromide combined with Flupenthixol Melitracen has a more pronounced effect on IBS-D patients and the symptoms of anxiety and depression can be improved significantly.

[Key words]Otilonium Bromide;Flupenthixol Melitracen;Diarrhea-predominant irritable bowel syndrome;Anxiety and depression

肠易激综合征(IBS)是临床常见的一组以腹痛、腹胀、腹部不适伴排便习惯改变为主要症状的临床综合征,属于消化系统的常见病、多发病,在消化内科门诊中约占就诊患者数的25%~30%。在罗马Ⅲ诊断标准中,根据粪便的性状,IBS被分为4个亚型,即腹泻型(IBS-D)、便秘型(IBS-C)、混合型(IBS-M)和未定型(IBS-U)。……

登录APP查看全文